Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 9.47% | $283.50M | £220.77B | 51.99% | 80 Outperform | |
| AstraZeneca | 8.89% | $266.26M | £210.86B | 19.89% | 80 Outperform | |
| Shell (UK) | 6.93% | $207.41M | £158.23B | 4.31% | 73 Outperform | |
| Unilever | 4.54% | $135.82M | £107.74B | -5.19% | 72 Outperform | |
| Rolls-Royce Holdings | 4.35% | $130.14M | £102.13B | 124.42% | 71 Outperform | |
| British American Tobacco | 4.07% | $121.88M | £94.95B | 36.88% | 71 Outperform | |
| Rio Tinto | 3.35% | $100.16M | £113.21B | 37.76% | 82 Outperform | |
| GlaxoSmithKline | 3.21% | $96.24M | £75.70B | 33.56% | 77 Outperform | |
| BP p.l.c. | 3.11% | $93.00M | £71.35B | 9.78% | 71 Outperform | |
| Barclays | 2.90% | $86.89M | £67.09B | 63.70% | 78 Outperform |